Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

TARA holding history

Protara Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TARA overviewAll 13F holders of TARAFull Q2 2026 holdings

Shares (Q2 2026)
251,500
Value
$960.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TARA by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026251,500$960.7K<0.1%+125,800+100.1%AddedHolders
Q1 2026125,700$654.9K<0.1%−141,107−52.9%ReducedHolders
Q4 2025266,807$1.42M<0.1%−47,493−15.1%ReducedHolders
Q3 2025314,300$1.37M<0.1%+165,100+110.7%AddedHolders
Q2 2025149,200$452.1K<0.1%+19,800+15.3%AddedHolders
Q1 2025129,400$551.2K<0.1%−12,900−9.1%ReducedHolders
Q4 2024142,300$751.3K<0.1%−194,440−57.7%ReducedHolders
Q3 2024336,740$616.2K<0.1%+186,340+123.9%AddedHolders
Q2 2024150,400$312.8K<0.1%+65,800+77.8%AddedHolders
Q1 202484,600$339.0K<0.1%−28,700−25.3%ReducedHolders
Q4 2023113,300$212.0K<0.1%+53,200+88.5%AddedHolders
Q3 202360,100$100.0K<0.1%−23,500−28.1%ReducedHolders
Q2 202383,600$200.0K<0.1%+24,694+41.9%AddedHolders
Q1 202358,906$184.0K<0.1%−8,094−12.1%ReducedHolders
Q4 202267,000$180.0K<0.1%−12,200−15.4%ReducedHolders
Q3 202279,200$234.0K<0.1%+25,000+46.1%AddedHolders
Q2 202254,200$159.0K<0.1%+16,600+44.1%AddedHolders
Q1 202237,600$192.0K<0.1%−27,200−42.0%ReducedHolders
Q4 202164,800$437.0K<0.1%−51,100−44.1%ReducedHolders
Q3 2021115,900$802.0K<0.1%+64,473+125.4%AddedHolders
Q2 202151,427$501.0K<0.1%+20,027+63.8%AddedHolders
Q1 202131,400$494.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.